Caprock Group, Inc. Omeros Corp Transaction History

Caprock Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$1.08 - $3.63 $7 - $25	-7 Reduced 0.01%	60,812 $198,000
Q3 2023 Oct 18, 2023	BUY	$2.81 - $5.69 $19 - $39	7 Added 0.01%	60,819 $177,000
Q4 2021 Jan 18, 2022	BUY	$5.67 - $8.54 $27,216 - $40,991	4,800 Added 8.57%	60,812 $391,000
Q3 2020 Oct 29, 2020	SELL	$9.57 - $21.32 $123,663 - $275,497	-12,922 Reduced 18.75%	56,012 $566,000
Q2 2020 Aug 05, 2020	SELL	$12.21 - $16.99 $123,223 - $171,463	-10,092 Reduced 12.77%	68,934 $1.02 Million
Q1 2020 Apr 28, 2020	BUY	$9.03 - $19.72 $116,098 - $253,540	12,857 Added 19.43%	79,026 $1.06 Million
Q4 2019 Feb 04, 2020	BUY	$13.01 - $17.15 $3,057 - $4,030	235 Added 0.36%	66,169 $932,000
Q1 2018 Apr 23, 2018	SELL	$9.0 - $20.16 $10,035 - $22,478	-1,115 Reduced 1.66%	65,934 $736,000
Q3 2017 Oct 23, 2017	BUY	$19.76 - $24.9 $1.32 Million - $1.67 Million	67,049	67,049 $1.45 Million

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $378M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Caprock Group, Inc. with notifications on news.